Combination Therapy of Sintilimab and Anlotinib as a First-line Treatment in Advanced NSCLC (SUNRISE)
Clinical trial NCT04124731 · UNKNOWN
Trial details
- NCT number
- NCT04124731
- Sponsor
- Shanghai Chest Hospital
- Status
- UNKNOWN
- Phase
- Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2019-10-01
- Primary completion
- 2021-04-01
- Enrollment
- 98
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.